Cerebral Infarction
147
14
17
70
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
15 trials with published results (10%)
Research Maturity
70 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.4%
8 terminated out of 147 trials
89.7%
+3.2% vs benchmark
26%
38 trials in Phase 3/4
21%
15 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (147)
Safely Quenching Complement in Stroke Survivors
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Bacteria in Atherosclerotic Plaques and Adverse Events
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke
Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
Research on Binaural Synchronous Vagus Nerve Regulation of Sensorimotor Disorders After Cerebral Infarction
Stroke Recovery Initiative - Registry for Stroke Research Studies
Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients.
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke
Thrombus Analysis of Ischemic Stroke
Cerebral Atherosclerosis Research With Positron Emission Tomography